Reply: Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
作者信息
Garin Etienne, Edeline Julien
机构信息
University of Rennes, CS 44229 Rennes F-35042, France E-mail:
出版信息
J Nucl Med. 2015 Jun;56(6):969. doi: 10.2967/jnumed.115.158006. Epub 2015 Apr 23.
PMID:25908828
Abstract
摘要
Zotero 插件